TPEX:7871 Revenue

Elixiron Immunotherapeutics (Cayman) Limited had revenue of 223.00K TWD in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 1.03M. In the year 2024, Elixiron Immunotherapeutics (Cayman) Limited had annual revenue of 803.00K, down -96.88%.

Revenue (ttm)

1.03M

Revenue Growth

-96.88%

P/S Ratio

8,258.24

Revenue / Employee

n/a

Employees

n/a

Market Cap

8.47B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	803.00K	-24.89M	-96.88%
Dec 31, 2023	25.70M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition